top of page
gradientForSurfBreak.png

Item List

Buesinesswire
COMPaSS™ Personalized Spine Surgery Study Begins Enrollment

Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track outcomes for a period of two years.

Recent Posts

Portfolio Company

Carlsmed.png

Regard and Kettering Health Hamilton Partner to Streamline EHR Navigation ...

PR Newswire

Portfolio Company

Carlsmed.png

Elektra Health Adds $3.3M in Seed Funding to Grow Its Platform for Evidence-base ...

FemTech Insider

Portfolio Company

Carlsmed.png

DeepScribe Launches New and Innovative Trust and Safety Suite for its Ambient AI ...

AIThority

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page